BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pu J, Zhang Y, Wang A, Qin Z, Zhuo C, Li W, Xu Z, Tang Q, Wang J, Wei H. ADORA2A-AS1 Restricts Hepatocellular Carcinoma Progression via Binding HuR and Repressing FSCN1/AKT Axis. Front Oncol 2021;11:754835. [PMID: 34733789 DOI: 10.3389/fonc.2021.754835] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Khorkova O, Stahl J, Joji A, Volmar C, Zeier Z, Wahlestedt C. Natural antisense transcripts as drug targets. Front Mol Biosci 2022;9:978375. [DOI: 10.3389/fmolb.2022.978375] [Reference Citation Analysis]
2 Qu X, Zhao X, Lin K, Wang N, Li X, Li S, Zhang L, Shi Y. M2-like tumor-associated macrophage-related biomarkers to construct a novel prognostic signature, reveal the immune landscape, and screen drugs in hepatocellular carcinoma. Front Immunol 2022;13:994019. [DOI: 10.3389/fimmu.2022.994019] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Stribbling SM, Ryan AJ. The cell-line-derived subcutaneous tumor model in preclinical cancer research. Nat Protoc 2022. [PMID: 35859135 DOI: 10.1038/s41596-022-00709-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Lu X, Zhao N, Duan G, Deng Z, Lu Y. Testis developmental related gene 1 promotes non-small-cell lung cancer through the microRNA-214-5p/Krüppel-like factor 5 axis. Bioengineered 2022;13:603-16. [PMID: 34856848 DOI: 10.1080/21655979.2021.2012406] [Reference Citation Analysis]